Abiopharma

Intensity Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

New Form 3 - Twist Bioscience Corp Filed: 2025-08-07 AccNo: 0001214659-25-011687 Size: 8 KB

Astrana Health, Inc. Reports Second Quarter 2025 Results

New Form 4 - Twist Bioscience Corp Filed: 2025-08-07 AccNo: 0001214659-25-011688 Size: 4 KB

Relmada Therapeutics Reports Second Quarter 2025 Financial Results and Announces NDV-01 6-Month Follow-up Safety and Efficacy Data in NMIBC

The Joint Corp. Reports Second Quarter 2025 Financial Results

AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation

New Form 10-Q - STERIS plc Filed: 2025-08-07 AccNo: 0001757898-25-000008 Size: 8 MB

New Form 10-Q - ARROWHEAD PHARMACEUTICALS, INC. Filed: 2025-08-07 AccNo: 0001628280-25-038858 Size: 9 MB

BioLife Solutions Reports Second Quarter 2025 Financial Results

10x Genomics Reports Second Quarter 2025 Financial Results

Avidity Biosciences Reports Second Quarter 2025 Financial Results and Recent Highlights

Owlet Reports Second Quarter 2025 Financial Results; Increases Full Year 2025 Guidance; Announces CEO Transition Plan

Trevi Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

New Form 8-K - DYNAVAX TECHNOLOGIES CORP Filed: 2025-08-07 AccNo: 0001029142-25-000115 Size: 310 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits